Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-20

Clinical Trial Update: Efficacy and Safety of Stapokibart in Non-Allergic Rhinitis With Eosinophilia Syndrome [NA]

View source ↗

Summary

This trial update describes the planned efficacy and safety study of Stapokibart for non-allergic rhinitis with eosinophilia syndrome, with the trial currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Stapokibart

Snippet

Sponsor: Huazhong University of Science and Technology | Conditions: Non-Allergic Rhinitis With Eosinophilia Syndrome | NA | Status: NOT_YET_RECRUITING